Flagship explainer
What drives VitaNova Life Sciences Corporation’s return on equity?
ROE is five filed business factors multiplied together.
| Input | Value | Fiscal year | Source |
|---|---|---|---|
| $850746 | FY2025 |
| |
| Income before tax | $1.2M | FY2025 |
|
| Operating income | $1.2M | FY2025 |
|
| $2.7M | FY2025 |
| |
| Ending assets | $2.3M | FY2025 |
|
| Beginning assets | $1.2M | FY2024 |
|
| $1.9M | FY2025 |
| |
| $1.1M | FY2024 |
|
Source:
- SEC filingFiling detailsAccession 0001683168-25-005368